InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Curhan Gregory S, 管理人员. Officer active across 1 company, notably Angion Biomedica Corp.. Aggregated, 1 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 15 December 2021. The latest transaction was filed on 15 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Gregory S. Curhan is associated with Angion Biomedica Corp. Although his specific role is not mentioned, he contributes to the company's leadership. His expertise and commitment are essential for the development and implementation of the company's initiatives.